[HTML][HTML] Antibiotics in the clinical pipeline as of December 2022

MS Butler, IR Henderson, RJ Capon… - The Journal of …, 2023 - nature.com
The need for new antibacterial drugs to treat the increasing global prevalence of drug-
resistant bacterial infections has clearly attracted global attention, with a range of existing …

ESKAPEing the labyrinth of antibacterial discovery

R Tommasi, DG Brown, GK Walkup… - Nature reviews Drug …, 2015 - nature.com
Antimicrobial drug resistance is a growing threat to global public health. Multidrug resistance
among the'ESKAPE'organisms—encompassing Enterococcus faecium, Staphylococcus …

Antibiotic resistance—the need for global solutions

R Laxminarayan, A Duse, C Wattal… - The Lancet infectious …, 2013 - thelancet.com
The causes of antibiotic resistance are complex and include human behaviour at many
levels of society; the consequences affect everybody in the world. Similarities with climate …

[HTML][HTML] New agents for the treatment of drug-resistant Mycobacterium tuberculosis

DT Hoagland, J Liu, RB Lee, RE Lee - Advanced drug delivery reviews, 2016 - Elsevier
Inadequate dosing and incomplete treatment regimens, coupled with the ability of the
tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have …

Aminoacyl-tRNA synthetases as therapeutic targets

NH Kwon, PL Fox, S Kim - Nature reviews Drug discovery, 2019 - nature.com
Aminoacyl-tRNA synthetases (ARSs) are essential enzymes for protein synthesis with
evolutionarily conserved enzymatic mechanisms. Despite their similarity across organisms …

The versatility of boron in biological target engagement

DB Diaz, AK Yudin - Nature Chemistry, 2017 - nature.com
Boron-containing molecules have been extensively used for the purposes of chemical
sensing, biological probe development and drug discovery. Due to boron's empty p orbital, it …

[HTML][HTML] Boron chemicals in drug discovery and development: Synthesis and medicinal perspective

BC Das, NK Nandwana, S Das, V Nandwana… - Molecules, 2022 - mdpi.com
A standard goal of medicinal chemists has been to discover efficient and potent drug
candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive …

Challenges and opportunities for the application of boron clusters in drug design

ZJ Lesnikowski - Journal of medicinal chemistry, 2016 - ACS Publications
There are two branches in boron medicinal chemistry: the first focuses on single boron atom
compounds, and the second utilizes boron clusters. Boron clusters and their heteroatom …

Leaks in the pipeline: a failure analysis of gram-negative antibiotic development from 2010 to 2020

NK Prasad, IB Seiple, RT Cirz… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
ABSTRACT The World Health Organization (WHO) has warned that our current arsenal of
antibiotics is not innovative enough to face impending infectious diseases, especially those …

The challenge of converting Gram‐positive‐only compounds into broad‐spectrum antibiotics

MF Richter, PJ Hergenrother - … of the New York Academy of …, 2019 - Wiley Online Library
Multidrug resistant Gram‐negative bacterial infections are on the rise, and there is a lack of
new classes of drugs to treat these pathogens. This drug shortage is largely due to the …